Valuation Amarin Corporation plc

Stocks

Market Closed - Nasdaq Other stock markets 23:00:00 08/07/2026 +03			5-day change	1st Jan Change
15.17 ^USD	-1.88%		-7.89%	+8.71%

07-02	European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading	MT
06-30	Amarin Corporation plc Reaffirms the Proven Guideline-Recommended Role of Vascepa (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,333	488.6	355.2	199.5	290.2	318.1	-	-
Change	-	-63.35%	-27.3%	-43.84%	45.45%	9.63%	-	-
Enterprise Value (EV) ¹	1,114	270.4	156	78.46	155.5	144.2	130.6	126.1
Change	-	-75.72%	-42.33%	-49.69%	98.19%	-7.25%	-9.44%	-3.46%
P/E	169x	-4.65x	-5.8x	-2.43x	-155x	-506x	-759x	-379x
PBR	2x	0.82x	0.64x	0.41x	-	-	-	-
PEG	-	0x	0.1x	-0.1x	1.6x	7.6x	22.8x	-4x
Capitalization / Revenue	2.29x	1.32x	1.16x	0.87x	1.36x	1.79x	2x	2.27x
EV / Revenue	1.91x	0.73x	0.51x	0.34x	0.73x	0.81x	0.82x	0.9x
EV / EBITDA	44.9x	-5.69x	-2.31x	-0.86x	-3.1x	-5.64x	-6.34x	-4.47x
EV / EBIT	46x	-3.64x	-2.31x	-0.85x	-3.1x	-5.64x	-6.34x	-4.47x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.4	-5.2	-3	-4	-0.09	-0.03	-0.02	-0.04
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	583.2	369.2	306.9	228.6	213.6	177.8	158.8	140.2
EBITDA ¹	24.81	-47.5	-67.43	-91.7	-50.17	-25.57	-20.61	-28.21
EBIT ¹	24.22	-74.26	-67.59	-91.8	-50.17	-25.58	-20.61	-28.21
Net income ¹	7.729	-105.8	-59.11	-82.18	-38.8	-12.75	-9.038	-16.28
Net Debt ¹	-219.5	-218.2	-199.3	-121	-134.7	-173.9	-187.5	-192
Reference price ²	67.40	24.20	17.40	9.70	13.96	15.17	15.17	15.17
Nbr of stocks (in thousands)	19,781	20,191	20,415	20,567	20,793	20,969	-	-
Announcement Date	3/1/22 A	3/1/23 A	2/29/24 A	3/12/25 A	2/25/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
AMARIN CORPORATION PLC	-515.33x	0.85x	-5.88x	-	324M
ARGENX SE	35.02x	8.81x	27.34x	0.05%	57.72B
WUXI APPTEC CO., LTD.	19.79x	6.09x	13.27x	1.53%	52.65B
INSMED INCORPORATED	-42.68x	14.17x	-41.28x	-.--%	24.46B
BIONTECH SE	-18.74x	4.62x	-8.07x	-.--%	23.84B
WUXI BIOLOGICS (CAYMAN) INC.	24.1x	4.75x	12.43x	-.--%	19.28B
GENMAB A/S	24.43x	4.87x	15.9x	-.--%	17.8B
PHARMAESSENTIA CORPORATION	51.77x	21.11x	56.65x	0.05%	17.29B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-536.63x	36.92x	-4116.16x	-.--%	15.28B
EXELIXIS, INC.	17.96x	5.22x	12.19x	-.--%	14.35B
Average	-94.03x	10.74x	-403.36x	0.18%	24.3B
Weighted average by Cap.	-19.52x	10.16x	-247.57x	0.35%